Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Inositol Supplementation to Treat PCOS (INSUPP-PCOS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial INSUPP-PCOS studying inositol supplementation for Polycystic Ovary Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inositol supplementation (myo-inositol)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Polycystic Ovary Syndrome, Anovulation | Phase 2 | Status: COMPLETED